ask="2.25"
ask_size="500"
average_daily_volume="2031390"
bid="2.22"
bid_size="2000"
book_value="1.31"
change="+0.07"
change_from_200_day_moving_average="-2.34"
change_from_50_day_moving_average="0.30"
change_from_52_week_high="-6.03"
change_From_52_week_low="0.99"
change_in_percent="+3.30%"
close="2.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.17"
ebitda="-77.46M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.56"
ex_dividend_date="N/A"
float_shares="63466000"
high="2.23"
high_52_weeks="8.22"
last_trade_date="2/16/2017"
last_trade_price="2.19"
last_trade_size="18007"
last_trade_time="4:00pm"
low="2.07"
low_52_weeks="1.20"
market_capitalization="163.31M"
moving_average_200_day="4.53"
moving_average_50_day="1.89"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="2.15"
pe_ratio="N/A"
peg_ratio="-0.56"
percent_change_from_200_day_moving_average="-51.69%"
percent_change_from_50_day_moving_average="+15.98%"
percent_change_from_52_week_high="-73.36%"
percent_change_from_52_week_low="+82.50%"
previous_close="2.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.61"
price_per_sales="35.29"
revenue="4.48M"
shares_outstanding="74569000"
short_ratio="6.97"
stock_exchange="NMS"
symbol="ARWR"
volume="2110499"
weeks_range_52="1.20 - 8.22"
